Inhibition of MCU forces extramitochondrial adaptations governing physiological and pathological stress responses in heart
Tyler P. Rasmussen,Yuejin Wu,Mei-ling A. Joiner,Olha M. Koval,Nicholas R. Wilson,Elizabeth D. Luczak,Qinchuan Wang,Biyi Chen,Zhan Gao,Zhiyong Zhu,Brett A. Wagner,Jamie Soto,Michael L. McCormick,William Kutschke,Robert M. Weiss,Liping Yu,Ryan L. Boudreau,E. Dale Abel,Fenghuang Zhan,Douglas R. Spitz,Garry R. Buettner,Long-Sheng Song,Leonid V. Zingman,Mark E. Anderson
DOI: https://doi.org/10.1073/pnas.1504705112
IF: 11.1
2015-07-07
Proceedings of the National Academy of Sciences
Abstract:Significance Mitochondrial Ca 2+ is a fundamental signal that allows for adaptation to physiological stress but a liability during ischemia-reperfusion injury in heart. On one hand, mitochondrial Ca 2+ entry coordinates energy supply and demand in myocardium by increasing the activity of matrix dehydrogenases to augment ATP production by oxidative phosphorylation. On the other hand, inhibiting mitochondrial Ca 2+ overload is promulgated as a therapeutic approach to preserve myocardial tissue following ischemia-reperfusion injury. We developed a new mouse model of myocardial-targeted transgenic dominant-negative mitochondrial Ca 2+ uniporter (MCU) expression to test consequences of chronic loss of MCU-mediated Ca 2+ entry in heart. Here we show that MCU inhibition has unanticipated consequences on extramitochondrial pathways affecting oxygen utilization, cytoplasmic Ca 2+ homeostasis, physiologic responses to stress, and pathologic responses to ischemia-reperfusion injury.